Belvedere Trading
FBT icon

Belvedere Trading’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Belvedere Trading’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$61.3K Buy
+225
New +$58.5K ﹤0.01% 793
2026
Q2 		– Sell
-100
Closed -$21.5K – 1087
2026
Q1 		$20.1K Buy
+100
New +$20.7K ﹤0.01% 632

Other funds holding FBT

Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Nilsine Partners
Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return
D.A. Davidson & Co
D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return
Bensler
Bensler Bellevue, Washington $1.06B AUM 29.38% 1-Year Est. Return
Csenge Advisory Group
Csenge Advisory Group Clearwater, Florida $2.53B AUM 18.15% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Kestra Advisory Services
Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return
Daymark Wealth Partners
Daymark Wealth Partners Cincinnati, Ohio $4.41B AUM 22.52% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Belvedere Trading's FBT Position: Q3 2026 in Review

Belvedere Trading opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026: 225 shares worth $61.3K. The stake represents ﹤0.01% of the portfolio and ranks #793 among its holdings. This is a return to the name: Belvedere Trading previously reported a position in FBT as recently as Q1 2026.

Belvedere Trading first reported a position in FBT in Q1 2026 and has held it in 2 quarters since. 189 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Belvedere Trading held 225 shares of First Trust NYSE Arca Biotechnology Index Fund worth $61.3K as of Q3 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Belvedere Trading position in Q3 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Belvedere Trading's portfolio in Q3 2026, its #793 holding.
  • Belvedere Trading first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and has held it in 2 quarters since.
  • 189 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Belvedere Trading's 13F filing for Q3 2026, filed 5 Nov 2026.